vs

Side-by-side financial comparison of AdvanSix Inc. (ASIX) and IMMERSION CORP (IMMR). Click either name above to swap in a different company.

IMMERSION CORP is the larger business by last-quarter revenue ($372.9M vs $359.9M, roughly 1.0× AdvanSix Inc.). AdvanSix Inc. runs the higher net margin — -0.8% vs -4.6%, a 3.8% gap on every dollar of revenue. On growth, IMMERSION CORP posted the faster year-over-year revenue change (750.4% vs 9.4%). Over the past eight quarters, IMMERSION CORP's revenue compounded faster (537.9% CAGR vs 3.4%).

AdvanSix Inc. is an American chemical company that produces nylon 6 and related chemicals such as caprolactam and ammonium sulfate fertilizers. It operated as Honeywell's Resins and Chemicals division until 2016, when it was spun off as a separate company. The unit accounted for 3 percent of Honeywell's sales at the time. For 2019, revenue is estimated at $1.4 billion. The company traces its lineage to the H. W. Jayne Company, established 1884 in Frankford, Pennsylvania.

Immersion Corporation is an Aventura, Florida based developer and licensor of touch feedback technology, also known as haptic technology. Immersion Corporation has been accused of being a patent troll. Founded in 1993 by Louis Rosenberg, it is currently headed by lawyer Francis Jose, who serves as both chief executive officer and general counsel.

ASIX vs IMMR — Head-to-Head

Bigger by revenue
IMMR
IMMR
1.0× larger
IMMR
$372.9M
$359.9M
ASIX
Growing faster (revenue YoY)
IMMR
IMMR
+741.0% gap
IMMR
750.4%
9.4%
ASIX
Higher net margin
ASIX
ASIX
3.8% more per $
ASIX
-0.8%
-4.6%
IMMR
Faster 2-yr revenue CAGR
IMMR
IMMR
Annualised
IMMR
537.9%
3.4%
ASIX

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
ASIX
ASIX
IMMR
IMMR
Revenue
$359.9M
$372.9M
Net Profit
$-2.8M
$-17.0M
Gross Margin
7.6%
Operating Margin
-0.7%
-2.8%
Net Margin
-0.8%
-4.6%
Revenue YoY
9.4%
750.4%
Net Profit YoY
-892.9%
-191.3%
EPS (diluted)
$-0.11
$-0.57

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ASIX
ASIX
IMMR
IMMR
Q4 25
$359.9M
Q3 25
$374.5M
Q2 25
$410.0M
$372.9M
Q1 25
$377.8M
$471.3M
Q4 24
$329.1M
$616.2M
Q3 24
$398.2M
Q2 24
$453.5M
$95.5M
Q1 24
$336.8M
$43.8M
Net Profit
ASIX
ASIX
IMMR
IMMR
Q4 25
$-2.8M
Q3 25
$-2.6M
Q2 25
$31.4M
$-17.0M
Q1 25
$23.3M
$24.1M
Q4 24
$352.0K
$30.8M
Q3 24
$22.3M
Q2 24
$38.9M
$26.4M
Q1 24
$-17.4M
$18.7M
Gross Margin
ASIX
ASIX
IMMR
IMMR
Q4 25
7.6%
Q3 25
6.8%
Q2 25
14.3%
Q1 25
14.2%
Q4 24
3.4%
Q3 24
14.4%
Q2 24
17.9%
Q1 24
0.9%
Operating Margin
ASIX
ASIX
IMMR
IMMR
Q4 25
-0.7%
Q3 25
-0.9%
Q2 25
7.7%
-2.8%
Q1 25
7.7%
7.5%
Q4 24
-3.9%
11.4%
Q3 24
7.5%
Q2 24
11.5%
23.7%
Q1 24
-7.0%
37.9%
Net Margin
ASIX
ASIX
IMMR
IMMR
Q4 25
-0.8%
Q3 25
-0.7%
Q2 25
7.7%
-4.6%
Q1 25
6.2%
5.1%
Q4 24
0.1%
5.0%
Q3 24
5.6%
Q2 24
8.6%
27.7%
Q1 24
-5.2%
42.5%
EPS (diluted)
ASIX
ASIX
IMMR
IMMR
Q4 25
$-0.11
Q3 25
$-0.10
Q2 25
$1.15
$-0.57
Q1 25
$0.86
$0.73
Q4 24
$0.02
$0.93
Q3 24
$0.82
Q2 24
$1.43
$0.81
Q1 24
$-0.65
$0.59

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ASIX
ASIX
IMMR
IMMR
Cash + ST InvestmentsLiquidity on hand
$19.8M
$161.4M
Total DebtLower is stronger
$103.1M
Stockholders' EquityBook value
$815.2M
$298.1M
Total Assets
$1.7B
$1.1B
Debt / EquityLower = less leverage
0.35×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ASIX
ASIX
IMMR
IMMR
Q4 25
$19.8M
Q3 25
$23.7M
Q2 25
$18.4M
$161.4M
Q1 25
$8.3M
$153.9M
Q4 24
$19.6M
$159.3M
Q3 24
$17.3M
Q2 24
$12.1M
$133.4M
Q1 24
$20.6M
$179.1M
Total Debt
ASIX
ASIX
IMMR
IMMR
Q4 25
Q3 25
Q2 25
$103.1M
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24
Stockholders' Equity
ASIX
ASIX
IMMR
IMMR
Q4 25
$815.2M
Q3 25
$818.2M
Q2 25
$823.7M
$298.1M
Q1 25
$794.4M
$317.9M
Q4 24
$774.6M
$305.5M
Q3 24
$766.4M
Q2 24
$746.6M
$273.4M
Q1 24
$713.2M
$201.5M
Total Assets
ASIX
ASIX
IMMR
IMMR
Q4 25
$1.7B
Q3 25
$1.7B
Q2 25
$1.6B
$1.1B
Q1 25
$1.6B
$1.4B
Q4 24
$1.6B
$1.4B
Q3 24
$1.5B
Q2 24
$1.5B
$1.2B
Q1 24
$1.5B
$244.7M
Debt / Equity
ASIX
ASIX
IMMR
IMMR
Q4 25
Q3 25
Q2 25
0.35×
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ASIX
ASIX
IMMR
IMMR
Operating Cash FlowLast quarter
$63.7M
Free Cash FlowOCF − Capex
$36.1M
FCF MarginFCF / Revenue
10.0%
Capex IntensityCapex / Revenue
7.7%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$6.4M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ASIX
ASIX
IMMR
IMMR
Q4 25
$63.7M
Q3 25
$26.6M
Q2 25
$21.1M
Q1 25
$11.4M
$-43.7M
Q4 24
$64.2M
Q3 24
$57.3M
Q2 24
$50.2M
$-85.9M
Q1 24
$-36.2M
$29.9M
Free Cash Flow
ASIX
ASIX
IMMR
IMMR
Q4 25
$36.1M
Q3 25
$66.0K
Q2 25
$-7.2M
Q1 25
$-22.6M
$-46.2M
Q4 24
$29.8M
Q3 24
$26.8M
Q2 24
$16.7M
Q1 24
$-71.6M
FCF Margin
ASIX
ASIX
IMMR
IMMR
Q4 25
10.0%
Q3 25
0.0%
Q2 25
-1.7%
Q1 25
-6.0%
-9.8%
Q4 24
9.1%
Q3 24
6.7%
Q2 24
3.7%
Q1 24
-21.3%
Capex Intensity
ASIX
ASIX
IMMR
IMMR
Q4 25
7.7%
Q3 25
7.1%
Q2 25
6.9%
Q1 25
9.0%
0.5%
Q4 24
10.4%
Q3 24
7.7%
Q2 24
7.4%
Q1 24
10.5%
Cash Conversion
ASIX
ASIX
IMMR
IMMR
Q4 25
Q3 25
Q2 25
0.67×
Q1 25
0.49×
-1.82×
Q4 24
182.29×
Q3 24
2.57×
Q2 24
1.29×
-3.25×
Q1 24
1.60×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ASIX
ASIX

Plant Nutrients$140.0M39%
Chemical Intermediates$92.8M26%
Caprolactam$64.4M18%
Nylon Resins$62.8M17%

IMMR
IMMR

Course Material Sale$150.9M40%
General Merchandise Sale$138.0M37%
Rental Services$51.8M14%
Services And Other Revenue$25.6M7%
Per Unit Royalties$1.8M0%

Related Comparisons